Back to search

Intensive chemotherapy with blood progenitor transplantation for primary resistant multiple myeloma

Data up to Jan 2025

Published1994
Citations31
References24

Total Citations Per Year

Abstract

References (24)

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

1975 • 3,051 citations

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION

1989 • 776 citations

GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR EXPANDS THE CIRCULATING HAEMOPOIETIC PROGENITOR CELL COMPARTMENT IN MAN

1988 • 585 citations

Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma

1991 • 538 citations

Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients

1991 • 519 citations

VAD‐based regimens as primary treatment for multiple myeloma

1990 • 320 citations

High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma

1987 • 270 citations

High Serum Lactate Dehydrogenase Level as a Marker for Drug Resistance and Short Survival in Multiple Myeloma

1991 • 203 citations

Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support

1992 • 177 citations

Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients

1992 • 174 citations

Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support

1992 • 143 citations

Double-intensive therapy in high-risk multiple myeloma

1992 • 133 citations

Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors

1990 • 130 citations

Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma

1993 • 128 citations

Prognostic implications of tumor cell DNA and RNA content in multiple myeloma

1985 • 113 citations

Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors

1990 • 101 citations

Double-intensive therapy in high-risk multiple myeloma

1992 • 98 citations

Myeloma protein kinetics following chemotherapy

1982 • 94 citations

Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma

1993 • 87 citations

Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma.

1993 • 49 citations

Cyclophosphamide and etoposide therapy with GM‐CSF for VAD‐resistant multiple myeloma

1993 • 43 citations

The Role of Autologous Blood Stem Cells in Support of High-dose Therapy for Multiple Myeloma

1992 • 30 citations

The Role of Interferon-α in the Management of Myelomatosis

1992 • 22 citations

Peripheral blood stem cell autografts in myeloma.

1990 • 5 citations

Cited By (0)

Loading...
Intensive chemotherapy with blood progenitor transplantation for primary resistant… (1994) – British Journal of Haematology | Metascience Observatory Explorer